| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |